Blog

A recent study confirms that the rarest and most deadly subtype of mesothelioma is less likely to show a positive response to chemotherapy treatment than other more common subtypes of mesothelioma. Scientists from the Mayo Clinic in Minnesota and the Levine Cancer Institute in North Carolina studied 1,475 mesothelioma patients and their response to first » Read More

Some new information from Australia provides interesting insight into survival rates for mesothelioma patients.  The Asbestos Diseases Research Institute and Sydney Medical School conducted a study in an area of the country long known for its asbestos mining industry.   More than 900 patients diagnosed with pleural mesothelioma were specifically analyzed for this research study. The » Read More

Researchers at Massachusetts General Hospital reported in March they are having success with a new type of cancer vaccine in tests on mice with ovarian cancer and mesothelioma.  This new approach would be easier and more cost effective than current treatments. Ovarian cancer and mesothelioma have little in common except they are both very difficult » Read More

The last Friday in September marked the tenth annual National Mesothelioma Awareness Day.  This annual awareness campaign has drawn much support and attention in the last decade.  As a result, gains have been made in research, advocacy, education, funding and treatment options for mesothelioma. National Mesothelioma Awareness Day has been an important part of educating » Read More